Bradenton, Florida Clinical Trials

A listing of Bradenton, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 37 clinical trials
A Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria

This is a study to determine the safety of multiple doses of CDX-0159 in patients with Chronic Spontaneous Urticaria.

Sarasota Clinical Research
 (7.1 away) Contact site
  • 0 views
  • 24 Sep, 2021
  • +8 other locations
Study of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin Lymphoma

The primary objective of this study is to determine the safety and tolerability of GS-0189 (formerly FSI-189) as monotherapy and in combination with rituximab in participants with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL).

rituximab
b-cell lymphoma
gilbert's syndrome
large b-cell lymphoma
cell transplantation
Florida Cancer Specialists
 (4.8 away) Contact site
  • 0 views
  • 31 Jul, 2021
  • +4 other locations
A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

The primary objective of this study is to evaluate the safety and tolerability of H3B-6545 and palbociclib when administered in combination in order to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of this combination in women with advanced or metastatic estrogen receptor-positive (ER+) HER2- …

EGFR
palbociclib
estrogen
estrogen receptor
cancer
Florida Cancer Specialists
 (4.8 away) Contact site
  • 13 views
  • 25 Jul, 2021
  • +11 other locations
RBN-2397 an Oral PARP7 Inhibitor in Patients With Solid Tumors FIH MAD Study

RBN-2397 inhibits PARP7, an enzyme that is switched on by cancer stresses, such as the toxins in cigarette smoke. Cancer cells use PARP7 to hide from the immune system by stopping the cell from sending a signal (Type 1 interferon) that tells the immune system that something is wrong and …

breast cancer
solid tumour
solid tumor
cancer
lymphoma
SCRI-Sarasota/Florida Cancer Specialists
 (5.4 away) Contact site
  • 3 views
  • 03 Sep, 2021
  • +7 other locations
A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread

The primary objective of this trial is to determine the maximum tolerated dose (MTD)/optimal biological dose (OBD) of BI 905681 given as an intravenous infusion and to determine the recommended dose and dosing schedule for further trials in the development of BI 905681. The MTD will be defined based on …

primary cancer
direct bilirubin
neutrophil count
growth factor
liver metastasis
Florida Cancer Specialists
 (5.4 away) Contact site
  • 0 views
  • 15 Sep, 2021
  • +2 other locations
RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

This study is a multi-center, open-label, dose escalation and expansion study of RLY-1971 in subjects with advanced or metastatic solid tumors.

neuropathy
solid tumour
SCRI-Sarasota/Florida Cancer Specialists
 (5.4 away) Contact site
  • 70 views
  • 24 Jul, 2021
  • +5 other locations
Phase 1/1b Study of Oral PMD-026 in Patients With Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer and triple negative breast cancer. PMD-026 is a targeted oral agent designed to kill tumor cells in metastatic breast cancer and triple negative breast cancer.

triple negative breast cancer
tumor cells
gilbert's syndrome
cancer
HER2
Florida Cancer Specialists & Research Institute
 (5.4 away) Contact site
  • 8 views
  • 30 Aug, 2021
  • +7 other locations
Study to Evaluate the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the Knee

This two-part study will be conducted in male and female patients, 30 - 80 years of age with painful OA of the index knee with Kellgren-Lawrence (K-L) Grade 2, 3 or 4. Part 1 - Single Ascending Dose (SAD) Phase: Up to three ascending doses of FX201 will be tested …

osteoarthritis
moderate pain
conservative management
hyaluronic acid
Gulfcoast Research Institute, LLC
 (5.4 away) Contact site
  • 51 views
  • 20 Aug, 2021
  • +8 other locations
A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors

Study SL-801-0115 is a dose-escalation study evaluating multiple doses and schedules of orally administered SL-801 in patients with Advanced Solid Tumors

platelet transfusion
platelet count
cancer
neutrophil count
liver metastasis
Florida Cancer Specialist
 (7.0 away) Contact site
  • 11 views
  • 26 Mar, 2021
  • +5 other locations
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of escalating doses of RMC-4630 monotherapy in adult participants with relapsed/refractory solid tumors and to identify the recommended Phase 2 dose (RP2D).

renal function test
cancer
KRAS
kidney function test
Sarah Cannon Research Institute - Florida Cancer Specialists
 (5.4 away) Contact site
  • 8 views
  • 07 Sep, 2021
  • +12 other locations